Company profile: Lutonix
1.1 - Company Overview
Company description
- Provider of a drug-coated balloon catheter (Lutonix DCB) that delivers paclitaxel to the arterial wall in a single, short inflation to treat arterial disease and prevent arterial restenosis, similar to a standard angioplasty balloon with a special paclitaxel coating.
Products and services
- Angioplasty-Style Balloon Platform: Balloon utilizes a special paclitaxel coating for single, short inflation arterial wall delivery, producing anti-proliferative effect to help prevent restenosis
- Lutonix DCB Drug-Coated Balloon Catheter: Drug-coated catheter delivers paclitaxel to the arterial wall during a single, short inflation to treat arterial disease and prevent restenosis, architected similar to angioplasty balloons
- Single-Inflation Paclitaxel Delivery: System supplies anti-proliferative paclitaxel to the arterial wall using a balloon catheter to treat arterial disease and mitigate restenosis
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Lutonix
Puzzle Medical
HQ: Canada
Website
- Description: Provider of minimally invasive long-term hemodynamic transcatheter pump solutions for advanced heart failure. Offers ModulHeart, a modular percutaneous heart pump supporting cardiac and renal function via multiple pumps anchored in parallel in the descending aorta, a portable controller with a long-life battery for autonomous operation, and a bedside monitoring station for cath lab programming and monitoring.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Puzzle Medical company profile →
Endosense
HQ: Switzerland
Website
- Description: Provider of medical technology to improve the efficacy, safety and reproducibility of catheter ablation for treating cardiac arrhythmias, including TactiCath, the first and only force-sensing ablation catheter that gives physicians a real-time, objective measure of contact force; CE marked in May 2009.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Endosense company profile →
VasoNova
HQ: United States
Website
- Description: Provider of medical devices, including a self-guided PICC catheter; develops, manufactures, and markets these products. Based in Sunnyvale, California.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full VasoNova company profile →
Capstan Medical
HQ: United States
Website
- Description: Provider of minimally invasive catheter-based technologies for heart valve disorders, including the Capstan Platform for treating mitral and tricuspid valve disease while the heart is beating, precision heart valve implants placed through a catheter, and surgical robotics integration to enhance procedure accuracy and reliability, offering a less invasive alternative to open heart surgery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Capstan Medical company profile →
Coherex Medical
HQ: United States
Website
- Description: Provider of medical devices addressing structural heart disease, including a patent foramen ovale (PFO) closure system designed to stimulate tissue in-growth for long-term closure, and the WaveCrest Left Atrial Appendage Occlusion System to close the left atrial appendage and reduce stroke risk in atrial fibrillation patients who cannot tolerate chronic oral anticoagulation therapy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Coherex Medical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Lutonix
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Lutonix
2.2 - Growth funds investing in similar companies to Lutonix
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Lutonix
4.2 - Public trading comparable groups for Lutonix
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →